For research use only
| Cat No. | ABC-SC0059T |
| Product Type | Human iPSCs |
| Cell Type | Neural Stem Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | iPSC |
| Disease | Alzheimer’s Disease |
| Storage | Liquid Nitrogen |
HighQC™ Human IPSC-Derived Neural Stem Cell-Alzheimer’s Disease Patient (APOE4 HOM) supports neurodegeneration modeling and APOE4-associated studies.
HighQC™ Human IPSC-Derived Neural Stem Cells-Alzheimer’s Disease Patient (APOE4 HOM) are derived from integration-free induced pluripotent stem cells (iPSCs) of Alzheimer’s disease (AD) patients with APOE4 homozygous (HOM) mutation under fully defined neural induction conditions. These human APOE4 neural stem cells express typical markers of cortical neural stem and progenitor cells, such as PAX6, FOXG1, and Nestin, and spontaneously form polarized neural rosette structures when seeded as monolayers. In addition, these cells can generate a range of electrically active cortical excitatory and inhibitory neurons and form functional synapses and circuits in vitro. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | HighQC™ Human IPSC-Derived Neural Stem Cell-Alzheimer’s Disease Patient (APOE4 HOM), hIPSC-NSC-AD-APOE4, Human IPSC Neural Stem Cells Alzheimer APOE4 Homozygous |
| Species | Human |
| Cat.No | ABC-SC0059T |
| Product Category | Stem Cells |
| Size/Quantity | 1 vial |
| Cell Type | Neural Stem Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | iPSC |
| Disease | Alzheimer’s Disease |
| Storage | Liquid Nitrogen |
| Product Type | Human iPSCs |
HighQC™ Human IPSC-Derived Neural Stem Cells-Alzheimer’s Disease Patient (APOE4 HOM) are ideal for modeling Alzheimer’s disease (AD) mechanisms in vitro. They enable studies on neuroinflammation, synaptic dysfunction, and APOE4-related tau pathology. The model facilitates high-throughput screening of AD therapeutics targeting neurodegeneration and lipid metabolism.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
The original iPSCs were reprogrammed from donor tissue using Sendai virus (non-integrating) per CytoTune™ iPS 2.0 protocols. Before cell banking and differentiation, qPCR confirmation ensures complete clearance of the virus, so no residual viral material remains in the iPSC Master/Working Banks or derived neural stem cells.
HighQC™ Human iPSC-Derived Neural Stem Cells–Alzheimer’s Disease Patient (APOE4 HOM) are supplied as a ready-to-use research cell product and are recommended for experimental use immediately after recovery. This product is not intended for long-term expansion, and optimization of propagation conditions may require user-specific protocols. The product is supplied for research use only (RUO) and is not intended for clinical or diagnostic applications. To ensure optimal cell performance, the recommended culture medium and coating matrix should be used. In addition, the use of this product is subject to the applicable product licensing and intellectual property terms.